reports
FERRARI RELEASES ITS 2025 ANNUAL REPORT AND FILES ANNUAL REPORT ON FOR...
FERRARI RELEASES ITS 2025 ANNUAL REPORT AND FILES ANNUAL REPORT ON FORM 20-F Maranello (Italy), February 19, 2026 - Ferrari N.V. (NYSE/EXM: RACE) announced today that it has published its 2025 Annual Report and filed with the United States Securities and Exchange Commission its annual report on Form 20-F, including financial statements for the fiscal year ended December 31, 2025. The 2025 Sustainability Statement, prepared in accordance with the requirements from the European Sustainability Reporting Standard (ESRS) on a voluntary basis, is included in the 2025 Annual Report. Ferrari’s 202...
DIVIDEND DISTRIBUTION PROPOSAL
DIVIDEND DISTRIBUTION PROPOSAL Maranello (Italy), February 19, 2026 - Ferrari N.V. (NYSE/EXM: RACE) (the “Company”) announced today that its Board of Directors intends to recommend to the Company’s shareholders a dividend distribution to the holders of common shares of Euro 3.615 per common share, with an increase of approximately 21% compared to the prior year and corresponding to a total distribution of approximately Euro 640 million. The distribution will be subject to its approval by the Annual General Meeting of Shareholders which is scheduled to be held on April 15, 2026. If shareho...
argenx to Report Full Year 2025 Financial Results and Fourth Quarter B...
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026 February 19, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 26, 2026 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2025 financial results and provide a fourth quarter business update. A webcast of the live call may be accessed on the Investors section of th...
- Pierre FerraguÊ
Disclosure of trading in own shares
Disclosure of trading in own shares Disclosure of trading in own shares on 02/13/2026 Paris – February 16, 2026 Share repurchase program approved by the Shareholders’ Meeting of May 27, 2025. Transaction Details: Publicis Groupe SA Name of the IssuerIdentity Code of the IssuerISINIntermediary NameIdentify Code of the IntermediaryCurrencyPublicis Groupe SA2138004KW8BV57III342FR0000130577BOFA SECURITIES EUROPE SA549300FH0WJAPEHTIQ77EUR Total number of shares purchased according to trading venues: Name of the IssuerIdentity code of the financial instrumentDay of the transactionTotal numbe...
Déclaration des transactions sur actions propres
Déclaration des transactions sur actions propres Déclaration des transactions sur actions propres réalisées le 13/02/2026 Paris – 16 février 2026 Programme de rachat d’actions adopté par l’Assemblée Générale du 27 mai 2025. Détails des Transactions pour Publicis Groupe SA Nom de l'émetteurCode identifiant de l'émetteur (code LEI)Code identifiant de l'instrument financier (ISIN)Nom du PSICode identifiant du PSIDevisePublicis Groupe SA2138004KW8BV57III342FR0000130577BOFA SECURITIES EUROPE SA549300FH0WJAPEHTIQ77EUR Nombre total d'actions rachetées par place de marché: Nom de l'émetteur Code...
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Maranello (Italy), February 16 2026 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 250 million share buyback program announced on December 16, 2025, as the first tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the “First Tranche”), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) a...
Execution of a 175 million euro share buyback agreement
Execution of a 175 million euro share buyback agreement Execution of a 175 million euro share buyback agreement Paris – February 12, 2026 – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] appointed as of today, an Investment Services Provider to implement a program for the acquisition of its own shares, for a maximum amount of 175 million euros. The purpose of this program is to satisfy the obligations arising under the existing free share long-term incentive plans in favor of its employees, without issuing new shares. This program will begin on February 13, 2026, and will end no l...
Mise en œuvre d’un programme de rachat d’actions de 175 millions d’eur...
Mise en œuvre d’un programme de rachat d’actions de 175 millions d’euros Mise en œuvre d’un programme de rachat d’actions de 175 millions d’euros Paris – le 12 février 2026 – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] a confié ce jour, un mandat à un Prestataire de Services d’Investissement pour l’exécution d’un programme portant sur l’achat de ses propres actions, pour un montant maximum de 175 millions d’euros. Ce programme a pour objectif de satisfaire aux obligations liées aux plans actuels d’actions gratuites au bénéfice des salariés, sans émettre de nouvelles actions. ...
- Ahmed Ben Salem
FP TOTAL SE
HEIA HEINEKEN NV
BVI BUREAU VERITAS SA
TKA TELEKOM AUSTRIA AG
GFC GECINA SA
ABB ABB LTD.
MF WENDEL SE
KER KERING SA
RAND RANDSTAD NV
SCHP SCHINDLER HOLDING AG PREF
RACE FERRARI NV
AD KONINKLIJKE AHOLD DELHAIZE N.V.
BP. BP P.L.C.
BG BAWAG GROUP AG
ENR SIEMENS ENERGY AG
DSY DASSAULT SYSTEMES SA
SGSN SGS SA
UN0 UNIPER SE
AENA AENA S.M.E. SA
TKMS TKMS AG & CO. KGAA
- Ahmed Ben Salem
HEIA HEINEKEN NV
BVI BUREAU VERITAS SA
TKA TELEKOM AUSTRIA AG
GFC GECINA SA
ABB ABB LTD.
MF WENDEL SE
KER KERING SA
RAND RANDSTAD NV
SCHP SCHINDLER HOLDING AG PREF
RACE FERRARI NV
AD KONINKLIJKE AHOLD DELHAIZE N.V.
BP. BP P.L.C.
BG BAWAG GROUP AG
ENR SIEMENS ENERGY AG
DSY DASSAULT SYSTEMES SA
SGSN SGS SA
UN0 UNIPER SE
AENA AENA S.M.E. SA
TKMS TKMS AG & CO. KGAA
- Anthony Dick
- Michael Foundoukidis
- Anthony Dick
- Michael Foundoukidis
STRONG PERFORMANCE IN 2025 SETS THE FOUNDATION FOR CONTINUED GROWTH IN...
STRONG PERFORMANCE IN 2025 SETS THE FOUNDATION FOR CONTINUED GROWTH IN 2026 STRONG PERFORMANCE IN 2025 SETS THE FOUNDATION FOR CONTINUED GROWTH IN 2026 Net revenues of Euro 7,146 million, up 7% versus prior yearOperating profit (EBIT) of Euro 2,110 million, up 12% versus prior year, with Operating profit (EBIT) margin of 29.5%Net profit of Euro 1,600 million and diluted EPS at Euro 8.96EBITDA of Euro 2,772 million, up 8% versus prior year, with EBITDA margin of 38.8%Industrial free cash flow of Euro 1,538 million, up 50% versus the prior year2026 guidance targeting Euro ~7.50 billion reve...
Novartis AG: 1 director
A director at Novartis AG sold 7,500 shares at 156.208USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM Maranello (Italy), February 9 2026 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 250 million share buyback program announced on December 16, 2025, as the first tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the “First Tranche”), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) as...
- Pierre FerraguÊ
Novartis breaks ground on new global Biomedical Research center in San...
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel, SwitzerlandApproximately 466,000-square-foot site with AI-enabled discovery capabilities, expected to house about 1,000 employees Part of a USD 23 billion US investment to expand R&D and advanced manufacturing to reach more patients East Hanover, February 6, 2026 – Novartis today broke ground on a new, s...
- Pierre FerraguÊ
- Aurelien Sivignon
- Thomas Zlowodzki
BEKB BEKAERT SA
ALLIX WALLIX GROUP SA
APAML APERAM SA
PHA PHARMAGEST INTERACTIVE SA
IAG INTERNATIONAL CONSOLIDATED AIRLINES GROUP SA
NRG NRJ GROUP SA
LNA LNA SANTE SA
GBT GUERBET SA
WIZZ WIZZ AIR HOLDINGS PLC
EZJ EASYJET PLC
RY4C RYANAIR HOLDINGS PLC
SAVE SAVENCIA SA
LIGHT SIGNIFY NV
XFAB X-FAB SILICON FOUNDRIES SE
DUFN DUFRY AG
ALD ALD SA
OBEL ORANGE BELGIUM SA
NVM NOVEM GROUP SA
AF AIR FRANCE - KLM
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.